Northwest Kidney Centers and Outset Medical Announce Collaboration to Grow Home Hemodialysis
Outset Medical (NASDAQ:OM) has announced a strategic collaboration with Northwest Kidney Centers to expand access to home hemodialysis using the Tablo® Hemodialysis System. Northwest Kidney Centers, pioneer of home hemodialysis programs, will integrate Tablo into their network where currently 20% of patients dialyze at home.
The Tablo system offers significant advantages, operating with standard tap water and electrical outlets, featuring a touchscreen interface and cloud connectivity. The collaboration aims to enhance patient care through Northwest Kidney Centers' comprehensive support system, including personalized training and 24/7 nursing access.
Outset Medical (NASDAQ:OM) ha annunciato una collaborazione strategica con Northwest Kidney Centers per ampliare l'accesso all'emodialisi domiciliare utilizzando il Tablo® Hemodialysis System. Northwest Kidney Centers, pioniere nei programmi di emodialisi domiciliare, integrerà Tablo nella propria rete dove attualmente il 20% dei pazienti si dializza a casa.
Il sistema Tablo offre vantaggi significativi: funziona con acqua di rete e prese elettriche standard, dispone di interfaccia touch-screen e connettività cloud. La collaborazione punta a migliorare l'assistenza ai pazienti grazie al sistema di supporto completo di Northwest Kidney Centers, che include formazione personalizzata e accesso infermieristico 24/7.
Outset Medical (NASDAQ:OM) ha anunciado una colaboración estratégica con Northwest Kidney Centers para ampliar el acceso a la hemodiálisis domiciliaria utilizando el Tablo® Hemodialysis System. Northwest Kidney Centers, pionero en programas de hemodiálisis en el hogar, integrará Tablo en su red donde actualmente el 20% de los pacientes se dializa en casa.
El sistema Tablo ofrece ventajas destacadas: funciona con agua de red y tomas eléctricas estándar, cuenta con pantalla táctil y conectividad en la nube. La colaboración busca mejorar la atención al paciente mediante el completo sistema de apoyo de Northwest Kidney Centers, que incluye capacitación personalizada y acceso de enfermería 24/7.
Outset Medical (NASDAQ:OM)은 Northwest Kidney Centers와 전략적 협력을 발표하고 Tablo® Hemodialysis System을 활용해 가정용 혈액투석 접근성을 확대합니다. 가정 혈액투석 프로그램의 선구자인 Northwest Kidney Centers는 현재 전체 환자의 20%가 가정에서 투석을 받고 있는 네트워크에 Tablo를 통합할 예정입니다.
Tablo 시스템은 수돗물과 일반 전기 콘센트로 작동하며 터치스크린 인터페이스와 클라우드 연결 기능을 갖추는 등 중요한 장점을 제공합니다. 이번 협력은 맞춤형 교육과 24시간 간호 지원을 포함한 Northwest Kidney Centers의 포괄적 지원 체계를 통해 환자 관리를 향상하는 것을 목표로 합니다.
Outset Medical (NASDAQ:OM) a annoncé une collaboration stratégique avec Northwest Kidney Centers pour étendre l'accès à l'hémodialyse à domicile en utilisant le Tablo® Hemodialysis System. Northwest Kidney Centers, pionnier des programmes d'hémodialyse à domicile, intégrera Tablo dans son réseau où actuellement 20% des patients se dialysent à domicile.
Le système Tablo présente des avantages significatifs : il fonctionne avec l'eau du réseau et des prises électriques standard, dispose d'une interface tactile et d'une connectivité cloud. Cette collaboration vise à améliorer les soins aux patients grâce au dispositif d'accompagnement complet de Northwest Kidney Centers, comprenant une formation personnalisée et un accès infirmier 24h/24 et 7j/7.
Outset Medical (NASDAQ:OM) hat eine strategische Zusammenarbeit mit den Northwest Kidney Centers angekündigt, um den Zugang zur häuslichen Hämodialyse mithilfe des Tablo® Hemodialysis System zu erweitern. Die Northwest Kidney Centers, Pionier bei Programmen zur Hämodialyse zu Hause, werden Tablo in ihr Netzwerk integrieren, in dem derzeit 20% der Patienten zu Hause dialysiert werden.
Das Tablo-System bietet erhebliche Vorteile: es arbeitet mit normalem Leitungswasser und Standardsteckdosen und verfügt über eine Touchscreen-Oberfläche sowie Cloud-Konnektivität. Die Zusammenarbeit zielt darauf ab, die Patientenversorgung durch das umfassende Unterstützungsangebot der Northwest Kidney Centers zu verbessern, einschließlich individueller Schulungen und 24/7-Pflegenotfallzugang.
- Partnership with Northwest Kidney Centers, a pioneer in home hemodialysis, enhances market credibility
- Access to Northwest Kidney Centers' established network where 20% of patients already dialyze at home
- Successful pilot phase showing positive patient engagement and adoption of Tablo system
- Tablo's simplified infrastructure requirements and user-friendly design reduce barriers to adoption
- No specific revenue projections or financial terms disclosed
- Limited to Puget Sound region initially
Insights
Outset's Tablo system partnership with Northwest Kidney Centers strengthens its market position in the growing home hemodialysis segment.
This partnership between Outset Medical and Northwest Kidney Centers represents a strategic expansion for Outset's Tablo Hemodialysis System into one of the nation's oldest and most respected kidney care networks. The collaboration is particularly significant as Northwest Kidney Centers has a substantial home dialysis program with nearly 20% of its patients currently dialyzing at home—well above the national average.
The Tablo system's key technological advantages make it particularly well-suited for home use. Unlike conventional home hemodialysis machines that require extensive plumbing modifications and specialized water purification systems, Tablo operates with standard tap water and electrical outlets. Its touchscreen interface and automated setup substantially reduce the technical barriers that have historically limited home hemodialysis adoption.
This partnership addresses one of the most pressing challenges in nephrology care—expanding access to home-based treatments. The
Feedback from the pilot phase indicating positive patient engagement and confidence with the Tablo system suggests this partnership could improve both patient retention rates in home hemodialysis programs and potentially expand the eligible patient population for home treatment—two critical metrics for Outset's long-term market penetration strategy.
Collaboration to provide patients and caregivers access to innovative home dialysis with the Tablo® Hemodialysis System
SAN JOSE, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Northwest Kidney Centers, the first organization to establish a home hemodialysis program, today announced a collaboration with Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company transforming the dialysis experience across the continuum of care. Through the collaboration, Northwest Kidney Centers will add Outset's Tablo Hemodialysis System to its offerings for patients in its network with the shared goal to expand access to home hemodialysis. With one of the largest and oldest home dialysis programs in the country, Northwest Kidney Centers has long championed patient independence and flexibility. Currently, nearly
“Northwest Kidney Centers has long prioritized patient independence and long-term success in home dialysis,” said Matthew Rivara, MD, Chief Medical Officer at Northwest Kidney Centers. “Our collaboration with Outset Medical and the integration of Tablo into our home program supports our commitment to innovation and patient-centered care. Patients who have used the Tablo system during our pilot phase report its intuitive design and ease of training have helped them stay engaged and confident in their treatment, which directly contributes to optimal quality of life for patients and the ability to continue to treat at home.”
Tablo is designed to operate with just tap water and a standard electrical outlet, eliminating the need for complex infrastructure. Its touchscreen interface, automated setup, and cloud-connected ecosystem make it easy to learn and use—by providers and patients.
“Tablo was built to simplify and reduce the burden of dialysis making it more accessible to patients,” said Michael Aragon, MD, Chief Medical Officer at Outset Medical. “We’re proud to collaborate with Northwest Kidney Centers, whose thought leadership in home dialysis is widely recognized, and aligns with our mission to innovate for better patient experiences and long-term success.”
This collaboration reflects a shared commitment to improving lives through not just technology, but through meaningful, community-rooted care. By bringing Tablo’s innovative home dialysis system to patients in the Puget Sound region, Northwest Kidney Centers and Outset Medical are expanding access to treatment that is easier to learn, more sustainable, and better aligned with patients’ daily lives.
Together, the organizations are helping more people live healthier, more independent lives at home, with dignity and confidence. As leaders in kidney care and innovation, Northwest Kidney Centers and Outset Medical are proud to support a future where dialysis is not only more accessible, but more empowering for every patient and family they serve.
About Northwest Kidney Centers
Northwest Kidney Centers is a nonprofit, community-based provider of kidney dialysis, public health education and research into the causes and treatments of chronic kidney disease. Founded in Seattle in 1962, it was the world’s first outpatient dialysis organization and today is the eighth-largest dialysis provider in the United States, serving more than 2,000 patients a year in 19 dialysis centers and eight hospitals in the Puget Sound region.
Northwest Kidney Centers’ mission is to promote the optimal health, quality of life and independence of people with kidney disease. Its patients have access to the first-in-the-nation kidney palliative care program, as well as an outpatient pharmacy staffed by kidney specialists. Through its long-standing partnership with the University of Washington, Northwest Kidney Centers helped establish the Kidney Research Institute in support of discoveries to better patients’ lives. For more information, visit www.nwkidney.org.
Contact
Stephanie Pitts
206-720-8510
About Outset Medical, Inc.
Outset is a medical technology company transforming the dialysis experience across the continuum of care with a first-of-its-kind technology. The Tablo® Hemodialysis System, FDA-cleared for use from hospital to home, is trusted by more than 1,000 U.S. healthcare facilities and has enabled millions of treatments delivered by thousands of nurses. Designed to reduce the cost and complexity of dialysis, Tablo combines water purification and on-demand dialysate production into a single, integrated system that connects seamlessly with Electronic Medical Record systems and a proprietary data analytics platform. This enterprise solution empowers providers to develop an in-house dialysis program where they are in control – enabling better operational, clinical, and financial outcomes. Outset is redefining what’s possible in kidney care through innovation, scale, and a relentless commitment to improving the lives of patients and the professionals who care for them. For more information, visit www.outsetmedical.com.
Contact
Jim Mazzola
jmazzola@outsetmedical.com
FAQ
What is the partnership between Outset Medical (NASDAQ:OM) and Northwest Kidney Centers?
What percentage of Northwest Kidney Centers patients currently use home dialysis?
What are the key features of Outset Medical's Tablo Hemodialysis System?
How does Northwest Kidney Centers support home dialysis patients?
What were the results of the Tablo system pilot phase at Northwest Kidney Centers?
